CLEC10A and cancer: The envelope glycoproteins of certain ERVs, including Emv2 in mice and HERV-K(HML2) in humans, have recently been suggested to initiate signaling cascades in immune and cancer cells, when ligated with anti-envelope antibodies (45–48).